The munKNEE.com Pure-Play Pot Stock Portfolio continues to perform poorly. It was down 7.7% this past week ending September 26 on the heels of 1.3%, 3.1% and 6.9% declines the previous three weeks, respectively. Only four of the constituents went up and two had no change in price. The winners and losers are as follows:

Major Winners

None of the four stocks that advanced during the week went up in excess of 10%. Medicine Man (SHWZ) went up 5.7%, the only stock to go up in excess of 5%.

Major Losers

Nineteen of the stocks in the portfolio (76%) finished the week down in price with ninr doing so in excess of 10%, namely:

1. Aurora (ACB) -22.7%
2. Avicanna (AVCNF) -14.4%
3. cbdMD (YCBD) -14.0%
4. Neptune (NEPT) -14.0%
5. Charlotte's Web (CWBHF) -13.5%
6. Canopy (CGC) -13.4%
7. Planet 13 (PLNHF) -13.1%
8. Valens (VLNCF) -10.5%
9. Tilray (TLRY) -10.3%

The 25 munKNEE.com Pure-Play Pot Stock Portfolio includes companies doing business in four categories based on their primary area of focus in the cannabis industry. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and it went down 7.5%, on average, last week vs. -1.2% the previous week and -2.9%  the week before that.
   • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB; CGC; APHA; CRON; OGI; ROMJF and TLRY) went down 11.8%, on average.
   • the 12 U.S. Multi-State Operator (MSOs) portfolio participants (ACRG; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; HRVSF; JUSHF;  PLNHF; SHWZ; TCNNF and TRSSF) went down 4.8% , on average.
   • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and YCBD) went down 13.7%, on average.
2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went down 12.7%, on average.
3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went down 9.3% vs. -6.2% the previous week and -9.7% the week before that.
4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went down 14.4%.

Please note: The 25 stocks in our Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, it reflects the true health of the marijuana industry in the U.S. and Canada.